Scroll to top
Tag: digital therapeutics
01/29/2023

With Digital Therapeutics, You Can Design Your Health

Article Excerpt: Digital health has emerged as a go-to-by thing during the last decade thanks to smart phones, mobile applications, wearable devices, cloud-based data platforms, social media platforms, and the like. The result is, that unlike the past, today’s patients… now have the freedom to participate in their own treatment decisions.

Full Article: https://tinyurl.com/4w8dfxhz

Article Source: ETHealthworld

12/20/2022

Bill Could Pave the Way for Prescription Digital Therapeutics Reimbursement

Article Excerpt: New legislation would allow for reimbursement of prescribed digital therapeutics under Medicare, which proponents argue could increase access to these emerging treatments. Still, others say it’s new technology, and the wrong reimbursement model could tamper innovation and increase patient costs. The Access to Prescription Digital Therapeutics Act of 2022, introduced in the U.S. Senate in March, aims to amend the Social Security Act to provide Medicare coverage and reimbursement for prescription digital therapeutics.

Full Article: https://tinyurl.com/464yhtr7

Article Source: MobiHealthNews

12/05/2022

Book Chapter Sneak Peak: Introduction And Aims of Digital Therapeutics for Mental Health and Addiction

Article Excerpt: In this first chapter, the book’s editors Jacobson, Kowatsch and Marsch “introduce a comprehensive overview of the field of digital therapeutics and research on their efficacy, effectiveness, scalability, and cost-effectiveness (pp. 1).” The authors are looking to introduce the topic of digital therapeutics to a broad audience and designed this book for people without a background in mental health or substance use. The authors’ vision includes conveying how advancements in technology can be leveraged to increase the effectiveness of interventions. Topics relating to structural considerations include the design of interventions, cultural adaptations, regulation, and data privacy.

Full Article: https://tinyurl.com/56jdnyae

Article Source: Centre for Digital Health Interventions News

11/10/2022

Digital Therapeutics Summit Held at Dartmouth

Article Excerpt: Nearly 175 people representing the digital health and pharmaceutical industries, health care systems, clinicians, scientists, investors, Dartmouth students and faculty, and government officials representing the National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA) gathered on Dartmouth’s campus November 2 for daylong discussions centered on digital therapeutics. Hosted by Geisel School of Medicine’s Center for Technology and Behavioral Health (CTBH) and Dartmouth’s Magnuson Center for Entrepreneurship, the program provided an overview of the science and clinical practice of digital therapeutics, the current and anticipated paths to their global deployment, and a vision for the future. This is the first time these groups have come together in conversations hosted by an academic institution about the digital health landscape and may well be viewed as a seminal moment in the rapidly developing field.

Full Article: https://tinyurl.com/2fnhbyxa

Article Source: Dartmouth Geisel School of Medicine News

11/08/2022

Register for Dartmouth Accelerator for Digital Health

Article Excerpt: DIADH, a partnership between the Center for Technology and Behavioral Health and the Magnuson Center for Entrepreneurship will help translate digital therapeutics and digital health innovations developed at Dartmouth into the marketplace. Registration to participate in DIADH is now open at https://www.c4tbh.org/accelerator/register. Dartmouth students, staff and faculty working to bring novel digital therapeutics and digital health tools to market will soon have a new resource available to them: the Dartmouth Innovation Accelerator for Digital Health (DIADH). The Accelerator was announced last week at “Clinically Validated Digital Therapeutics: Paths to Deployment,” an international summit hosted in Hanover by the Center for Technology and Behavioral Health (CTBH), an NIH-recognized National Center of Excellence within the Geisel School of Medicine at Dartmouth, and the Magnuson Center for Entrepreneurship at Dartmouth. The Summit brought together players from across the healthcare industry — including providers, payers, researchers, developers, regulators, and investors — for the first time to discuss the future of digital therapeutics and digital health. This is an area of healthcare that encompasses any software used to prevent, treat, or manage a medical disorder or disease. In addition, several Dartmouth faculty members who are affiliated with CTBH described the exciting work that is being at Dartmouth to bring world-class science to this important new area of healthcare. “There was a focus on problem solving and removing barriers in the industry so that we can accelerate the impact of digital health tools on people’s lives,” says Lisa A. Marsch, Ph.D., Director of CTBH.

Full Article: https://tinyurl.com/493eb29m

Article Source: Vox Daily

10/31/2022

Digital Health Summit Brings Together Leaders In Digital Therapeutics

Article Excerpt: Players from across the healthcare industry — including providers, payers, researchers, regulators and investors — will converge on Hanover Wednesday, November 2 for a digital health summit entitled “Clinically Validated Digital Therapeutics: Paths to Deployment.” The event, hosted by the Center for Technology and Behavioral Health (CTBH) and The Magnuson Center for Entrepreneurship at Dartmouth College, will cover the current state of digital therapeutics, and explore the paths to global deployment of this innovative type of healthcare. “We have a community, here at Dartmouth, that’s very well known for expertise in digital therapeutics,” says Lisa A. Marsch, Ph.D., Director of CTBH. CTBH is a nationally recognized Center of Excellence, funded by the National Institute on Drug Abuse.

Full Article: https://tinyurl.com/mryf2uvj

Article Source: The Magnuson Center Blog

10/23/2022

Can VR Act as A Digital Therapeutic?

Article Excerpt: Our digital, two-dimensional lives leave little room for focus. Our eyes dart from screen to screen over the course of the day as notifications and messages draw our attention away from tasks, from relaxation, from the faces of our loved ones. Through all of its flatness, our digital lives are dominated by distraction—so much so that we can sometimes forget to breathe. Finding lasting inner peace from within this flattened world can be a neurological nightmare. Mindfulness and meditation apps, digital health’s answer in the last decade, use many of the same engagement methods that have propelled other consumer applications like games and fitness apps to success. Strategies like achievements and social connectivity have kept many users coming back to engage in evidence-based, clinically effective therapies. But even the most effective and engaging mindfulness apps can’t transcend the noise and distraction of our everyday lives.

Full Article: https://tinyurl.com/mryfpr8m

Article Source: Fast Company

09/14/2022

Physician Adoption of Digital Health Tools Is Accelerating, AMA Research Shows

Article Excerpt: The American Medical Association’s digital health research released today shows increased rates of digital health adoption among physicians over the last six years and provides insights into their expectations. “The AMA survey illustrates the importance physicians place on validated digital health tools that improve health while streamlining the technological and administrative burdens faced each day in medicine,” said AMA President Dr. Jack Resneck Jr. in a statement. “These technologies also must be designed and deployed in ways that advance health equity,” he added.

Full Article: https://tinyurl.com/ykvhp5jz

Article Source: Health IT News

08/02/2022

How Much Are Patients Actually Using Mental Health Apps? Research on Engagement Is Elusive

Article Excerpt: As companies selling health care apps struggle to prove to a skeptical system that they really deliver results, we’re about to start hearing a lot more about “engagement.” A new paper scrutinizing six clinical trials supporting four mental health apps cleared by the Food and Drug Administration argues there’s an urgent need to close the “gap between intention and real-world efficacy for digital therapeutics” — specifically, the dearth of data on how much people actually use digital treatments.

Full Article: https://tinyurl.com/nxu5kryh

Article Source: STAT News